Healthcare EDI Market By End Users (Healthcare Providers, Medical Equipment And Accessories Suppliers/Pharmacies), By Product (Component, Type Of Transaction, Mode Of Delivery, EDI Van, Mobile EDI), Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global healthcare EDI market has been expected to grow at the CAGR of 12.7 % during 2016-2022 and is expected to reach $3150 million till 2022.Electronic Data Interchange (EDI), is an advanced electronic communication technology that offers exchange data standards, for exchange of data into any kind of electronic technology.The EDI or Electronic data exchange permits interchange of important data between two or more companies, situated in different countries, by application of assured standards of EDI.EDI can be defined as, exchange of data, by using encoded message terms and standards, from one computer device to another, without any human or mechanical interference.EDI has been playing anappreciated role in the healthcare sector as it is very difficult to manage the data in healthcare field such as medication data, emergency services records, patient history records, and others. EDI is applicable in almost all sub-division of healthcare sector, asit saves a lot of money and time, and ultimately drives the healthcare industry. As of now, major usage of EDI in the healthcare industry includes dental and medical patient database management, clinical trials, regulatory data management, insurance& reimbursement sector and others.
The market of healthcare EDI is driven by many influencing factors such as growing prevalence of chronic diseases &rising awareness, technological enhancement and its applications in the healthcare industry. This is supported by rapidly rising clinical trials and R&D, increasing base of end-users such as private players &hospitals, and strong focus on reimbursement &insurance claims. Rapidly enhancing technological applications is considered as the most important catalysts supporting the growth of the global healthcare EDI market. But, limited technological access in under developed and rural region of the world, threat of loss of system database due to technical issues are some of the limitations, anticipated to hinder the growth of global healthcare EDI market. Financial limitations also act as a barrier in the penetration of EDI.
Market Segment Insight
The global healthcare EDI market is majorly segmented into end user, product and regional outlook. In end user segment, market is divided into healthcare providers and medical equipment and accessories suppliers/ pharmacies. The healthcare providers is subdivided into healthcare payers, government/ public payers and private payers.In product segment, market is divided into component, type of transaction, mode of delivery EDI van and mobile EDI. Component segment is subdivided into software and services. Type of transaction segment is subdivided into claim status, eligibility verification, payment remittance, referral certification, enrollment/ disenrollment transactions and premium payment. Mode of delivery segment is subdivided into web based EDI/ EDI cloud, EDI via AS2 and Point to point EDI.In regional outlook segment, market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is having maximum market share of global healthcare EDI market. Asia Pacific is growing at a very faster rate, due to growing population and rising chronic diseases patients. Europe and Rest of the world is showing positive growth.
Regional Insight
Globally, the global healthcare EDI market is divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates global healthcare EDI market. U.S. has been the leader in development of IT infrastructure for the healthcare industry and is a deep-rooted market for healthcare IT solutions. But, there aremore growth opportunity for the healthcare EDI market in the North American countries considering the presence of large hospitals in the U.S., demanding advanced IT solutions to streamline the processes and availability of government funding for healthcare providers towards the development of health care services. Europe region is also showing positive growth rate due to government funding towards the healthcare sector. Asia Pacific region is fastest growing market and it will grow further in the forecasted period. Government initiatives for the support of healthcare IT, large population, and growing burden of diseases are some of the factor promoting growth inAsia Pacific region. Rest of the world is showing lucrative growth in the next five years, because of penetration of healthcare sector and it services in this region.
Competitive Insights
Some ofthekey market players are Linoma software, Interactive Intelligence, Emdeon Inc.,Zirmed Inc., Allscripts Healthcare solutions Inc., Siemens Healthcare, Plexis healthcare systems Inc., Passport health communication Inc., Omnivex Corporation, Mckesson Corporation, etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market.
CHAP 1. METHODOLOGY & SCOPE 13
1.1. RESEARCH METHODOLOGY 13
1.2. RESEARCH SCOPE & ASSUMPTIONS 13
1.3. LIST OF DATA SOURCES 13
CHAP 2. EXECUTIVE SUMMARY 14
2.1. GLOBAL HEALTHCARE EDI MARKET SUMMARY & KEY BUYING CRITERIA 14
2.2. GLOBAL HEALTHCARE EDI MARKET OUTLOOK 14
2.3. MARKET SEGMENTATION ANALYSIS 14
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
2.5. GLOBAL HEALTHCARE EDI MARKET VALUE CHAIN ANALYSIS 14
2.6. VENDOR LANDSCAPE 14
CHAP 3. GLOBAL HEALTHCARE EDI MARKET 15
3.1. MARKET DRIVER ANALYSIS 15
3.1.1. THE HEALTHCARE INSURANCE PORTABILITY AND ACCOUNTABILITY ACT, 1886, TO PROPEL THE ADOPTION OF EDI IN HEALTHCARE 15
3.1.2. PATIENT PROTECTION AND AFFORDABILITY CARE ACT 15
3.1.3. INITIATIVES BY DIFFERENT GOVERNMENT FOR ENCOURAGEMENT OF HEALTHCARE IT 15
3.2. MARKET RESTRAINT ANALYSIS 15
3.2.1. HIGH COST OF EDI SOFTWARE 15
3.2.2. RESTRICTED INVESTMENT IN HEALTHCARE IT 15
3.2.3. LIMITED REIMBURSEMENT TO HINDER THE GROWTH IN THE BRIC NATIONS 15
3.3. KEY OPPORTUNITIES 15
3.3.1. INCREASE IN THE OUTSOURCING OF EDI SERVICES 15
3.3.2. CONVERSION FROM ICD-8 TO ICD-10 15
3.4. CHALLENGES 15
3.4.1. DATA SECURITY—A MAJOR CONCERN FOR PATIENTS AND EDI USERS 15
3.4.2. EDI MANAGEMENT 15
CHAP 4. INDUSTRY ANALYSIS 16
4.1. GLOBAL HEALTHCARE EDI MARKET– PORTER’S FIVE FORCE MODEL 16
4.2. GLOBAL HEALTHCARE EDI MARKET– PESTEL ANALYSIS 16
4.3. GLOBAL HEALTHCARE EDI MARKET– GAP ANALYSIS 16
CHAP 5. GLOBAL HEALTHCARE EDI MARKET BY END USERS 2012-2022 ($ MILLION) 17
5.1. GLOBAL HEALTHCARE EDI MARKET BY HEALTHCARE PROVIDERS 2012-2022 ($ MILLION) 17
5.2. GLOBAL HEALTHCARE EDI MARKET BY MEDICAL EQUIPMENT AND ACCESSORIES SUPPLIERS/PHARMACIES 2012-2022 ($ MILLION) 17
CHAP 6. GLOBAL HEALTHCARE EDI MARKET BY PRODUCT 2012-2022 ($ MILLION) 18
6.1. GLOBAL HEALTHCARE EDI MARKET BY COMPONENT 2012-2022 ($ MILLION) 19
6.2. GLOBAL HEALTHCARE EDI MARKET BY TYPE OF TRANSACTION 2012-2022 ($ MILLION) 19
6.3. GLOBAL HEALTHCARE EDI MARKET BY MODE OF DELIVERY 2012-2022 ($ MILLION) 19
6.4. GLOBAL HEALTHCARE EDI MARKET BY EDI VAN 2012-2022 ($ MILLION) 19
6.5. GLOBAL HEALTHCARE EDI MARKET BY MOBILE EDI 2012-2022 ($ MILLION) 20
CHAP 7. GLOBAL HEALTHCARE EDI MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 21
7.1. GLOBAL HEALTHCARE EDI MARKET BY REGION 2012-2022 ($ MILLION) 21
7.2. NORTH AMERICA 21
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.2.3.1. U.S. 21
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.2.3.2. CANADA 21
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.2.3.3. MEXICO 21
7.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.3. EUROPE 22
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
7.3.3.1. GERMANY 22
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.2. UK 22
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.3. FRANCE 22
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.4. SPAIN 22
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.5. ITALY 22
7.3.3.5.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.3.3.5.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.3.3.6. REST OF EUROPE 23
7.3.3.6.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 23
7.3.3.6.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 23
7.4. ASIA PACIFIC 23
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
7.4.3.1. CHINA 23
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3.2. INDIA 23
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3.3. JAPAN 23
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 23
7.4.3.4. SOUTH KOREA 23
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 24
7.4.3.5. REST OF APAC 24
7.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
7.5. REST OF THE WORLD 24
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 24
7.5.3.1. LATIN AMERICA 24
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
7.5.3.2. MIDDLE EAST AND AFRICA 24
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
CHAP 8. COMPETITIVE LANDSCAPE 25
8.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC. 26
8.1.2. SCOT ANALYSIS 26
8.1.3. PRODUCT BENCHMARKING 26
8.1.4. STRATEGIC INITIATIVES 26
8.2. CAPARIO INC. 26
8.2.2. SCOT ANALYSIS 26
8.2.3. PRODUCT BENCHMARKING 26
8.2.4. STRATEGIC INITIATIVES 26
8.3. CONCENTRIX CORPORATION 26
8.3.2. SCOT ANALYSIS 26
8.3.3. PRODUCT BENCHMARKING 26
8.3.4. STRATEGIC INITIATIVES 26
8.4. EMDEON INC. 26
8.4.2. PRODUCT BENCHMARKING 26
8.4.3. STRATEGIC INITIATIVES 26
8.5. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY) 26
8.5.2. SCOT ANALYSIS 26
8.5.3. PRODUCT BENCHMARKING 26
8.5.4. STRATEGIC INITIATIVES 26
8.6. INTERACTIVE INTELLIGENCE 26
8.6.2. SCOT ANALYSIS 26
8.6.3. PRODUCT BENCHMARKING 27
8.6.4. STRATEGIC INITIATIVES 27
8.7. LINOMA SOFTWARE 27
8.7.2. SCOT ANALYSIS 27
8.7.3. PRODUCT BENCHMARKING 27
8.7.4. STRATEGIC INITIATIVES 27
8.8. MCKESSON CORPORATION 27
8.8.2. SCOT ANALYSIS 27
8.8.3. PRODUCT BENCHMARKING 27
8.8.4. STRATEGIC INITIATIVES 27
8.9. OMNIVEX CORPORATION 27
8.9.2. SCOT ANALYSIS 27
8.9.3. PRODUCT BENCHMARKING 27
8.9.4. STRATEGIC INITIATIVES 27
8.10. OPTUM INC. 27
8.10.2. SCOT ANALYSIS 27
8.10.3. PRODUCT BENCHMARKING 27
8.10.4. STRATEGIC INITIATIVES 27
8.11. PASSPORT HEALTH COMMUNICATIONS INC. 27
8.11.2. SCOT ANALYSIS 27
8.11.3. PRODUCT BENCHMARKING 27
8.11.4. STRATEGIC INITIATIVES 27
8.12. PLEXIS HEALTHCARE SYSTEMS, INC. 28
8.12.2. SCOT ANALYSIS 28
8.12.3. PRODUCT BENCHMARKING 28
8.12.4. STRATEGIC INITIATIVES 28
8.13. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG.) 28
8.13.2. SCOT ANALYSIS 28
8.13.3. PRODUCT BENCHMARKING 28
8.13.4. STRATEGIC INITIATIVES 28
8.14. SSI GROUP INC. 28
8.14.2. SCOT ANALYSIS 28
8.14.3. PRODUCT BENCHMARKING 28
8.14.4. STRATEGIC INITIATIVES 28
8.15. ZIRMED INC. 28
8.15.2. SCOT ANALYSIS 28
8.15.3. PRODUCT BENCHMARKING 28
8.15.4. STRATEGIC INITIATIVES 28
TABLE 1 GLOBAL HEALTHCARE EDI MARKET BY END USERS 2012-2022 ($ MILLION) 28
TABLE 2 GLOBAL HEALTHCARE EDI MARKET BY HEALTHCARE PROVIDERS 2012-2022 ($ MILLION) 28
TABLE 3 GLOBAL HEALTHCARE EDI MARKET BY HEALTHCARE PAYERS 2012-2022 ($ MILLION) 28
TABLE 4 GLOBAL HEALTHCARE EDI MARKET BY GOVERNMENT/PUBLIC PAYERS 2012-2022 ($ MILLION) 29
TABLE 5 GLOBAL HEALTHCARE EDI MARKET BY PRIVATE PAYERS 2012-2022 ($ MILLION) 29
TABLE 6 GLOBAL HEALTHCARE EDI MARKET BY MEDICAL EQUIPMENT AND ACCESSORIES SUPPLIERS/PHARMACIES 2012-2022 ($ MILLION) 29
TABLE 7 GLOBAL HEALTHCARE EDI MARKET BY PRODUCT 2012-2022 ($ MILLION) 29
TABLE 8 GLOBAL HEALTHCARE EDI MARKET BY COMPONENT 2012-2022 ($ MILLION) 29
TABLE 9 GLOBAL HEALTHCARE EDI MARKET BY SOFTWARE 2012-2022 ($ MILLION) 29
TABLE 10 GLOBAL HEALTHCARE EDI MARKET BY SERVICES 2012-2022 ($ MILLION) 29
TABLE 11 GLOBAL HEALTHCARE EDI MARKET BY TYPE OF TRANSACTION 2012-2022 ($ MILLION) 29
TABLE 12 GLOBAL HEALTHCARE EDI MARKET BY CLAIM STATUS 2012-2022 ($ MILLION) 29
TABLE 13 GLOBAL HEALTHCARE EDI MARKET BY ELIGIBILITY VERIFICATION 2012-2022 ($ MILLION) 29
TABLE 14 GLOBAL HEALTHCARE EDI MARKET BY PAYMENT REMITTANCE 2012-2022 ($ MILLION) 29
TABLE 15 GLOBAL HEALTHCARE EDI MARKET BY REFERRAL CERTIFICATION AUTHORIZATION 2012-2022 ($ MILLION) 29
TABLE 16 GLOBAL HEALTHCARE EDI MARKET BY ENROLLMENT/DISENROLLMENT TRANSACTIONS 2012-2022 ($ MILLION) 29
TABLE 17 GLOBAL HEALTHCARE EDI MARKET BY PREMIUM PAYMENTS 2012-2022 ($ MILLION) 29
TABLE 18 GLOBAL HEALTHCARE EDI MARKET BY MODE OF DELIVERY 2012-2022 ($ MILLION) 29
TABLE 19 GLOBAL HEALTHCARE EDI MARKET BY WEB-BASED EDI/EDI CLOUD 2012-2022 ($ MILLION) 29
TABLE 20 GLOBAL HEALTHCARE EDI MARKET BY EDI VIA AS2 2012-2022 ($ MILLION) 29
TABLE 21 GLOBAL HEALTHCARE EDI MARKET BY POINT-TO-POINT EDI 2012-2022 ($ MILLION) 30
TABLE 22 GLOBAL HEALTHCARE EDI MARKET BY EDI VAN 2012-2022 ($ MILLION) 30
TABLE 23 GLOBAL HEALTHCARE EDI MARKET BY MOBILE EDI 2012-2022 ($ MILLION) 30
TABLE 24 GLOBAL HEALTHCARE EDI MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 30
TABLE 25 GLOBAL HEALTHCARE EDI MARKET BY REGION 2012-2022 ($ MILLION) 30
TABLE 26 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 27 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 28 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
TABLE 29 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 30 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 31 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 32 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 33 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 34 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 35 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 36 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 37 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
TABLE 38 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 39 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 40 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 41 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 42 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 43 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 44 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 45 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 46 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 47 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 48 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 31
TABLE 49 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 50 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 51 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 52 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 31
TABLE 53 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 54 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 55 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 56 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 57 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 58 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 59 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 60 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 61 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 62 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 63 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 64 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 65 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 32
TABLE 66 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 67 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 68 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 69 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 33
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)